Soluble interleukin-2 (IL-2) receptor expression in patients with myelodysplastic syndromes is induced by granulocyte-macrophage colony-stimulating factor and IL-3

Blood. 1991 Jun 15;77(12):2795-6.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology*
  • Humans
  • Interleukin-3 / pharmacology*
  • Myelodysplastic Syndromes / blood*
  • Receptors, Interleukin-2 / biosynthesis*

Substances

  • Interleukin-3
  • Receptors, Interleukin-2
  • Granulocyte-Macrophage Colony-Stimulating Factor